Doctor of Osteopathy Program year 2023 Reported 2020–2023 Source: CMS Open Payments, 2026 publication

Wendy Kim

Dermatology Maywood, IL Doctor of Osteopathy

NPI 1790930477 CMS profile 81954

2160 S 1St Ave, Maywood, IL 60153

Open in the dashboard

General payments

$133

2 records reported · program years 2020–2023

Research payments

$0

Paid to them · None reported · program years 2020–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$6,560 paid to institutions, not to them · program years 2021–2025

Through program year 2023, Wendy Kim of Maywood, IL is reported in the CMS Open Payments database as having received $133 across 2 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,560 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 11th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $114 1
2020 General $19 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wendy Kim
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Wendy Kim were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Wendy Kim Dermatology median Middle half National median
2019 $0 $454 $129–$1,240 $163
2020 $19 $235 $81–$756 $114
2021 $0 $377 $108–$1,108 $132
2022 $0 $514 $143–$1,391 $149
2023 $114 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2020–2023
  1. Regeneron Healthcare Solutions, Inc. $114 1 payment
  2. Genzyme Corporation $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2023
  1. Food and Beverage $133 2 payments
Products named General payments · program years 2020–2023
  1. DUPIXENT Inflammation And Immunology $114 1 payment
  2. DUPIXENT Immunology $39 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

683

Median for Dermatology: 534

Drug cost

$265,369

Median for Dermatology: $67,151

Branded share of claims

12%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tremfya Guselkumab Brand 13 $123,553
Dupixent Pen Dupilumab Brand 18 $63,193
Dupixent Syringe Dupilumab Brand 18 $56,587
Tacrolimus Generic 43 $7,170
Ketoconazole Generic 144 $2,785
Clobetasol Propionate Generic 44 $2,447
Metronidazole Generic 40 $2,031
Fluorouracil Generic 25 $1,486
Clindamycin Phosphate Generic 25 $1,337
Fluocinonide Generic 28 $791

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$59,925

Medicare's payments for the services billed

Medicare patients

478

Average age 73

Services billed

1,708

271 women, 207 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 44%
Ischemic heart disease 23%
Diabetes 22%
Cancer 20%
Osteoporosis 19%
Atrial fibrillation 15%
Chronic kidney disease 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record